International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 1 , Pages 6-12 , 1 January 2006

Pathogenic role of the renin–angiotensin system in modulating radiation-induced late effects

  • Mike E. Robbins, Ph.D.

      Affiliations

    • Departments of Radiation Oncology, Neurosurgery, and Cancer Biology, Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • Corresponding Author InformationReprint requests to: Mike E. Robbins, Ph.D., Wake Forest University School of Medicine, Department of Radiation Oncology, Room #409 NRC, Medical Center Blvd., Winston-Salem, NC 27157. Tel: (336) 713-7635; Fax: (336) 713-7639
    • ,
  • Debra I. Diz, Ph.D.

      Affiliations

    • Hypertension and Vascular Disease Center, General Surgery, Wake Forest University School of Medicine, Winston-Salem, NC

Received 23 June 2005 ,Revised 5 August 2005 ,Accepted 10 August 2005.

References 

  1. Coleman CN , Stone HB , Moulder JE , et al.   Modulation of radiation injury . Science . 2004;304:693–694
  2. Stone HB , Coleman CN , Anscher MS , et al.   Effects of radiation on normal tissue (Consequences and mechanisms) . Lancet Oncol . 2003;4:529–536
  3. Withers HR , Peters LJ , Kogelnik HS . The pathobiology of late effects in irradiation . In:  Meyn RE ,  Withers HR editor. Radiation biology in cancer research . New York: Raven Press; 1980;p. 439–448
  4. Rubin P , Casarett GW . Clinical radiation pathology as applied to curative radiotherapy . Cancer . 1968;22:767–778
  5. Jaenke RS , Robbins MEC , Bywaters T , et al.   Capillary endothelium (Target site of renal radiation injury) . Lab Invest . 1993;57:551–565
  6. Schultheiss TE , Stephens LC . Permanent radiation myelopathy . Br J Radiol . 1992;65:737–753
  7. Rubin P , Finkelstein J , Shapiro D . Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes (Interrelationship between the alveolar macrophages and the septal fibroblast) . Int J Radiat Oncol Biol Phys . 1992;24:93–101
  8. Denham JW , Hauer-Jensen M . The radiotherapeutic injury—a complex “wound” . Radiother Oncol . 2002;63:129–145
  9. Moulder J , Robbins MEC , Cohen EP , et al.   Pharmacologic modification of radiation-induced late normal tissue injury . In:  Mittal BB ,  Purdy JA ,  Ang KK editor. Radiation therapy . Norwell, MA: Kluwer; 1998;p. 129–151
  10. Stone HB , McBride WH , Coleman CN . Modifying normal tissue damage postirradiation . Radiat Res . 2002;157:204–223
  11. Dent P , Yacoub A , Contessa J , et al.   Stress and radiation-induced activation of multiple intracellular signaling pathways . Radiat Res . 2003;159:283–300
  12. Martin M , Lefaix JL , Delanian S . TGF-β1 and radiation fibrosis (A master switch and a specific therapeutic target?) . Int J Radiat Oncol Biol Phys . 2000;47:277–290
  13. Lavoie JL , Sigmund CD . Minireview (Overview of the renin-angiotensin system—an endocrine and paracrine system) . Endocrinology . 2003;144:2179–2183
  14. Kambayashi Y , Bhardan S , Takahashi K , et al.   Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition . J Biol Chem . 1993;268:24543–24546
  15. Mukoyama M , Nakajima M , Horiuchi M , et al.   Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors . J Biol Chem . 1993;268:24539–24542
  16. Kang J , Posner P , Sumners C . Angiotensin type II receptor stimulation of neuronal K+ currents involves an inhibitory G protein . Am J Physiol . 1994;267:C1289–C1297
  17. Zhang J , Pratt RE . The AT2 receptor selectively associates with Gia2 and Gia3 in the rat fetus . J Biol Chem . 1996;271:15026–15033
  18. Klickstein LB , Kaempfer CE , Wintroub BU . The granulocyte-angiotensin system. Angiotensin I-converting enzyme activity of cathepsin G . J Biol Chem . 1982;257:15042–15046
  19. Schiller PW , Demassieux S , Boucher R . Substrate specificity of tonin from rat submaxillary gland . Circ Res . 1976;39:629–632
  20. Baltatu O , Nishimura H , Hoffman S , et al.   High levels of human chymase expression in the pineal and pituitary glands . Brain Res . 1997;752:269–278
  21. Chappell MC , Tallant EA , Brosnihan KB , et al.   Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line . Peptides . 1990;11:375–380
  22. Yamamoto K , Chappell MC , Brosnihan KB , et al.   In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats . Hypertension . 1992;19:692–696
  23. Chappell MC , Tallant EA , Brosnihan KB , et al.   Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells . J Vasc Biol Med . 1995;5:129–137
  24. Santos RAS , Brosnihan KB , Jacobsen DW , et al.   Production of Ang-(1-7) by human vascular endothelium . Hypertension . 1992;19(Suppl. II):II-56–II-61
  25. Wright JW , Harding  . The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory . Prog Neurobiol . 2004;72:263–293
  26. Donoghue M , Hsieh F , Baronas E , et al.   A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 . Circ Res . 2000;87:E1–E9
  27. Tipnis SR , Hooper NM , Hyde R , et al.   A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase . J Biol Chem . 2000;275:33238–33243
  28. Burrell LM , Johnston CI , Tikellis C , et al.   ACE2, a new regulator of the renin-angiotensin system . Trends Endocrinol Metab . 2004;15:166–169
  29. Chappell MC , Modrall JG , Diz DI , et al.   Novel aspects of the renal renin-angiotensin system (Angiotensin-(1-7), ACE2 and blood pressure regulation) . Contrib Nephrol . 2004;143:77–89
  30. Engeli S , Negrel R , Sharma AM . Physiology and pathophysiology of the adipose tissue renin-angiotensin system . Hypertension . 2000;35:1270–1277
  31. Davisson RL . Physiological genomic analysis of the brain renin-angiotensin system . Am J Physiol Regul Integr Comp Physiol . 2003;285:R498–R511
  32. Bader M , Peters J , Baltatu O , et al.   Tissue renin-angiotensinogen systems (New insights from experimental animal models in hypertension research) . J Mol Med . 2001;79:76–102
  33. Mulrow PJ . The intrarenal renin angiotensin . Curr Opin Nephrol Hypertens . 1993;2:41–44
  34. Chappell MC , Diz DI , Gallagher PE . The renin-angiotensin system and the exocrine pancreas . JOP . 2001;2:33–39
  35. Speth RC , Daubert DL , Grove KL . Angiotensin II (A reproductive hormone too?) . Regul Pept . 1999;79:25–40
  36. Nielsen AH , Schauser KH , Poulsen K . The uteroplacental renin-angiotensin system . Placenta . 2000;21:468–477
  37. Piepho RW . Overview of the angiotensin-converting enzyme inhibitors . Am J Health Syst Pharm . 2000;57:S3–S7
  38. Basso N , Paglia N , Stella I , et al.   Protective effect of the inhibition of the renin-angiotensin system on aging . Regul Pept . 2005;128:247–252
  39. Kasper SO , Basso N , Kurnjek ML , et al.   Divergent regulation of circulation and intra-renal renin-angiotensin systems in response to long-term blockade . Am J Nephrol . 2005;25:335–341
  40. Tedesco MA , Ratti G , Di Salvo G , et al.   Does the angiotensin II receptor antagonist losartan improve cognitive function? . Drugs Aging . 2002;19:723–732
  41. Gilliam-Davis S , Payne VS , Kasper SO , et al.   Differential regulation of circulating and intra-renal renin-angiotensin systems and improved metabolic function in Fisher 344 rats after long-term AT1 receptor blockade . Hypertension . 2005;46:818
  42. Diz DI , Gilliam-Davis S , Payne VS , et al.   Effects of chronic AT1 receptor blockade on blood pressure, insulin, leptin and body weight in Fisher 344 rats one year post-whole brain irradiation . Hypertension . 2005;46:831
  43. Cohen EP , Robbins MEC . Radiation nephropathy . Semin Nephrol . 2003;23:486–499
  44. Robbins MEC , Hopewell JW . Physiological factors affecting renal radiation tolerance (A guide to the treatment of late effects) . Br J Cancer . 1986;53(Suppl. VII):265–267
  45. Cohen EP , Fish BL , Moulder JE . Treatment of radiation nephropathy with captopril . Radiat Res . 1992;132:346–350
  46. Moulder JE , Cohen EP , Fish BL , et al.   Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme . Radiat Res . 1993;136:404–407
  47. Moulder JE , Fish BL , Cohen EP . Treatment of radiation nephropathy with ACE inhibitors . Int J Radiat Oncol Biol Phys . 1993;27:93–99
  48. Geraci JP , Sun MC , Mariano MS . Amelioration of radiation nephropathy in rats by postirradiation treatment with dexamethasone and/or captopril . Radiat Res . 1995;143:58–68
  49. Juncos LI , Carrasco Duenas S , et al.   Long-term enalapril and hydrochlorothiazide in radiation nephritis . Nephron . 1993;64:249–255
  50. Moulder JE , Fish BL , Cohen EP . Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist . Radiother Oncol . 1998;46:307–315
  51. Cohen EP , Moulder JE , Fish BL , et al.   Prophylaxis of experimental bone marrow transplant nephropathy . J Lab Clin Med . 1994;124:371–380
  52. Moulder JE , Fish BL , Cohen EP . Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy . Bone Marrow Transplant . 1997;19:729–735
  53. Cohen EP , Fish BL , Moulder JE . Successful brief captopril treatment in experimental radiation nephropathy . J Lab Clin Med . 1997;129:536–547
  54. Moulder JE , Fish BL , Cohen EP , et al.   Angiotensin II receptor antagonists in the prevention of radiation nephropathy . Radiat Res . 1996;146:106–110
  55. Moulder JE , Fish BL , Cohen EP . ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy . Curr Pharm Des . 2003;9:737–749
  56. Cohen EP , Hussain S , Moulder JE . Successful treatment of radiation nephropathy with angiotensin II blockade . Int J Radiat Oncol Biol Phys . 2003;55:190–193
  57. Kang PM , Landau AJ , Eberhardt RT , et al.   Angiotensin II receptor antagonists (A new approach to blockade of the renin-angiotensin system) . Am Heart J . 1994;127:1388–1401
  58. Cohen EP , Fish BL , Moulder JE . Angiotensin II infusion exacerbates radiation nephropathy . J Lab Clin Med . 1999;134:283–291
  59. Robbins MEC , Campling D , Rezvani M , et al.   Radiation nephropathy in mature pigs following irradiation of both kidneys . Int J Radiat Biol . 1989;56:83–98
  60. Cohen EP , Fish BL , Moulder JE . The renin-angiotensin system in experimental radiation nephropathy . J Lab Clin Med . 2002;139:251–257
  61. Moulder JE , Fish BL , Cohen EP . Impact of angiotensin type 2 receptor blockade on experimental radiation nephropathy . Radiat Res . 2004;161:312–317
  62. Marks LB , Yu X , Vujaskovic Z , et al.   Radiation-induced lung injury . Semin Radiat Oncol . 2003;13:333–345
  63. Zakheim RM , Mattioli L , Molteni A , et al.   Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin-1-converting enzyme in the rat . Lab Invest . 1975;38:57–61
  64. Molteni A , Ward WF , Ts’ao C , et al.   Monocrotaline-induced pulmonary fibrosis in rats (Amelioration by captopril and penicillamine) . Proc Soc Exp Biol Med . 1985;180:112–120
  65. Ward WF , Kim YT , Molteni A , et al.   Radiation-induced pulmonary endothelial dysfunction in rats (Modification by an inhibitor of angiotensin converting enzyme) . Int J Radiat Oncol Biol Phys . 1988;15:135–140
  66. Ward WF , Molteni A , Ts’ao C , et al.   Captopril reduces collagen and mast cell accumulation in irradiated rat lung . Int J Radiat Oncol Biol Phys . 1990;19:1405–1409
  67. Ward WF , Molteni A , Tsao C , et al.   Radiation pneumotoxicity in rats (Modification by inhibitors of angiotensin converting enzyme) . Int J Radiat Oncol Biol Phys . 1992;22:623–625
  68. Molteni A , Moulder JE , Cohen EP , et al.   Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker . Int J Radiat Biol . 2000;76:523–532
  69. Jemal A , Murray T , Ward E , et al.   Cancer statistics, 2005 . CA Cancer J Clin . 2005;55:10–30
  70. Patchell RA . The management of brain metastases . Cancer Treat Rev . 2003;29:533–540
  71. Shaw EG , Robbins ME . Central nervous system. Radiation toxicity: A practical guide . New York: Kluwer Academic Publishers; 2005; In press
  72. Imperato JP , Paleologos NA , Vick NA . Effects of treatment on long-term survivors with malignant astrocytomas . Ann Neurol . 1990;28:818–822
  73. Crossen JR , Garwood D , Glatstein E , et al.   Neurobehavioral sequelae of cranial irradiation in adults (A review of radiation-induced encephalopathy) . J Clin Oncol . 1994;12:627–642
  74. Johannesen TB , Lien HH , Hole KH , et al.   Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy . Radiother Oncol . 2003;69:169–176
  75. Yoneoka Y , Satoh M , Akiyama K , et al.   An experimental study of radiation-induced cognitive dysfunction in an adult rat model . Br J Radiol . 1999;72:1196–1201
  76. Culman J , Blume A , Gohlke P , et al.   The renin-angiotensin system in the brain (Possible therapeutic implications for AT1-receptor blockers) . J Hum Hypertens . 2002;16:S64–S70
  77. McKinley MJ , Albiston AL , Allen AM , et al.   The brain renin-angiotensin system (Location and physiological roles) . Int J Biochem Cell Biol . 2003;35:901–918
  78. Gard PR . The role of angiotensin II in cognition and behaviour . Eur J Pharmacol . 2002;438:1–14
  79. Wyss JM , Kadish I , van Groen T . Age-related decline in spatial learning and memory (Attenuation by captopril) . Clin Exp Hypertens . 2003;25:455–474
  80. Kim JH , Brown SL , Kolozsvary A , et al.   Modification of radiation injury by ramipril, inhibitor of angiotensin-converting enzyme, on optic neuropathy in the rat . Radiat Res . 2004;161:137–142
  81. Brown WR , Thore CR , Moody DM , et al.   Vascular damage after fractionated whole-brain irradiation in rats . Radiat Res. . 2005; in press
  82. Oden SD , Carter C , Ferrario CM , et al.   Influence of the brain renin-angiotensin system on cognitive ability during aging . Hypertension . 2002;40:381
  83. Dubey RK , Jackson EK , Rupprecht HD , et al.   Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells . Curr Opin Nephrol Hypertens . 1997;6:88–105
  84. Border WA , Noble NA . Interactions of transforming growth factor-β and angiotensin II in renal fibrosis . Hypertension . 1998;31:181–188
  85. Gomez-Garre D , Ruiz-Ortega M , Ortego M , et al.   Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth . Hypertension . 1996;27:885–892
  86. Kagami S , Kuhara T , Okada K , et al.   Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells . Kidney Int . 1997;51:664–671
  87. Vaughan DE . Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease . Eur Heart J . 1998;19(Suppl. G):G9–G12
  88. Suzuki Y , Ruiz-Ortega M , Lorenzo O , et al.   Inflammation and angiotensin II . Int J Biochem Cell Biol . 2003;35:881–900
  89. Blume A , Herdegen T , Unger T . Angiotensin peptides and inducible transcription factors . J Mol Med . 1999;77:339–357
  90. Saavera JM , Ando H , Armando I , et al.   Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists . Regul Pept . 2005;128:227–238
  91. Zhou J , Ando H , Macova M , et al.   Angiotensin II AT(1) receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats . J Cereb Blood Flow Metab . 2005; in press
  92. Black PH . Stress and the inflammatory response (A review of neurogenic inflammation) . Brain Behav Immun . 2002;16:622–653
  93. Monje ML , Toda H , Palmer TD . Inflammatory blockade restores adult hippocampal neurogenesis . Science . 2003;302:1760–1765
  94. Rola R , Raber J , Rizk A , et al.   Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice . Exp Neurol . 2004;188:316–330
  95. Hanna IR , Taniyama Y , Szöcs K , et al.   NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling . Antioxid Redox Signal . 2002;4:899–914
  96. Rinckel L , Faris S , Hitt N , et al.   Rac1 disrupts p67phox/p47phox binding (A novel role of Rac in NADPH oxidase activation) . Biochem Biophys Res Commun . 1999;263:118–122
  97. Li J-M , Shah A . Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells . J Biol Chem . 2002;277:19952–19960
  98. Griendling K , Sorescu D , Ushio-Fukai M . NADPH oxidase (Role in cardiovascular biology and disease) . Circ Res . 2000;86:494–501
  99. Rhee SG , Chang TS , Bae YS , et al.   Cellular regulation by hydrogen peroxide . J Am Soc Nephrol . 2003;14(Suppl. 3):S211–S215
  100. Griendling K , Minieri C , Ollerenshaw J , et al.   Angiotensin II stimulated NADH and NADPH oxidase activity in cultured vascular smooth muscle cells . Circ Res . 1994;74:1141–1148
  101. Zimmerman MC , Dunlay RP , Lazartiques E , et al.   Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotenisn II in the brain . Circ Res . 2004;95:532–539
  102. Karlsson A , Dahlgren C . Assembly and activation of the neutrophil NADPH oxidase in granule membranes . Antioxid Redox Signal . 2002;4:49–60
  103. Vinsant S , Chappell MC , Ferrario CM , et al.   Low glial angiotensinogen is not associated with deficits in angiotensin peptides in neuronal pathways in transgenic ASrAogen rats . [Abstract] FASEB J . 2005;19:A1188
  104. Garcia-Espinosa MA , Gallagher PE , Ferrario CM , et al.   Neprilysin and ACE2 regulation during aging in rats with low brain angiotensinogen . Hypertension . 2005; in press
  105. Robbins MEC , Zhao W . Chronic oxidative stress and radiation-induced late normal tissue injury (A review) . Int Radiat Biol . 2004;80:251–259
  106. Oparil S . Are there meaningful differences in blood pressure control with current antihypertensive agents? . Am J Hypertens . 2002;15:14S–21S
  107. Molteni A , Ward WF , Ts’ao CH , et al.   Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptors . Curr Pharm Des . 2003;9:751–761

 Supported in part by NIH grants DK51612, CA82722, and HL51952.

PII: S0360-3016(05)02578-2

doi: 10.1016/j.ijrobp.2005.08.033

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 1 , Pages 6-12 , 1 January 2006

Article Tools

* Image Usage & Resolution